Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Sanofi
  6. News
  7. Summary
    SAN   FR0000120578

SANOFI

(SAN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

SANOFI : Receives a Buy rating from JP Morgan

07/30/2021 | 04:01am EDT

JP Morgan is positive on the stock with a Buy rating. The target price has been raised to EUR 100 from EUR 93.


© MarketScreener with dpa-AFX Analyser 2021
All news about SANOFI
09/18PRESS RELEASE : FDA Advisory Committee Votes -3-
DJ
09/16VC DAILY : Venture Capitalists Push Back Against Drug-Pricing Bill
DJ
09/16PRESS RELEASE : HMNC Brain Health Initiates Pioneering Precision Therapy Program..
DJ
09/15TRANSLATE BIO : LifeSci Index Partners
AQ
09/14TRANSLATE BIO : Sanofi Completes Translate Bio Buyout
MT
09/14SANOFI : Closes On Acquisition Of Translate Bio
MT
09/14SANOFI : completes acquisition of Translate Bio, accelerating the application of..
PU
09/14SANOFI : completes acquisition of Translate Bio, accelerating the application of..
AQ
09/13VALNEVA : stock slumps after Britain ends COVID vaccine deal
RE
09/13NH TherAguix annonce l'approbation de son -2-
DJ
More news
Analyst Recommendations on SANOFI
More recommendations
Financials
Sales 2021 37 415 M 43 869 M 43 869 M
Net income 2021 6 046 M 7 089 M 7 089 M
Net Debt 2021 7 878 M 9 237 M 9 237 M
P/E ratio 2021 17,1x
Yield 2021 4,04%
Capitalization 102 B 120 B 120 B
EV / Sales 2021 2,95x
EV / Sales 2022 2,69x
Nbr of Employees 99 412
Free-Float 88,4%
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | SAN | FR0000120578 | MarketScreener
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 81,55 €
Average target price 104,66 €
Spread / Average Target 28,3%
EPS Revisions
Managers and Directors
Paul Hudson Chief Executive Officer & Director
Jean-Baptiste Chasseloup de Chatillon Chief Financial Officer & Executive Vice President
Serge Weinberg Chairman
John C. Reed EVP & Global Head-Research & Development
Nestle Frank Global Head-Immunology Therapeutic Research Area
Sector and Competitors
1st jan.Capi. (M$)
SANOFI3.62%120 158
JOHNSON & JOHNSON4.68%433 701
ROCHE HOLDING AG10.97%321 442
PFIZER, INC.20.81%246 078
NOVO NORDISK A/S50.80%232 556
ELI LILLY AND COMPANY36.28%208 604